PKAIX
Price
$13.49
Change
+$0.05 (+0.37%)
Updated
Dec 23 closing price
VIVAX
Price
$66.30
Change
-$0.14 (-0.21%)
Updated
Dec 23 closing price
Ad is loading...

PKAIX vs VIVAX

Header iconPKAIX vs VIVAX Comparison
Open Charts PKAIX vs VIVAXBanner chart's image
PIMCO RAE US Instl
Price$13.49
Change+$0.05 (+0.37%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$66.30
Change-$0.14 (-0.21%)
VolumeN/A
CapitalizationN/A
PKAIX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PKAIX vs. VIVAX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PKAIX is a StrongBuy and VIVAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 195B vs. PKAIX (1.56B). PKAIX pays higher dividends than VIVAX: PKAIX (2.62) vs VIVAX (2.25). PKAIX was incepted earlier than VIVAX: PKAIX (10 years) vs VIVAX (32 years). PKAIX is a more actively managed with annual turnover of: 77.00 vs. VIVAX (10.00). VIVAX has a lower initial minimum investment than PKAIX: VIVAX (3000) vs PKAIX (1000000). VIVAX annual gain was more profitable for investors over the last year : 15.09 vs. PKAIX (2.46). VIVAX return over 5 years is better than : 42.89 vs. PKAIX (26.25).
PKAIXVIVAXPKAIX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years32 years-
Gain YTD1.88814.38113%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.56B195B1%
Annual Yield % from dividends2.622.25117%
Returns for 1 year2.4615.0916%
Returns for 3 years5.2217.9229%
Returns for 5 years26.2542.8961%
Returns for 10 yearsN/A99.89-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GHRS7.000.15
+2.19%
GH Research PLC
EVEX5.090.08
+1.60%
Eve Holding
BEST2.640.02
+0.76%
BEST
HALO47.160.20
+0.43%
Halozyme Therapeutics
MCK576.76-2.98
-0.51%
McKesson Corp